Infection with cytomegalovirus (CMV) is extremely common, but the virus only becomes pathogenic when the immune system is weakened, by, for example, HIV or anti-rejection transplant immunosupressors.

Northwestern Medicine scientists have discovered how a common virus linked to birth defects and chronic illness manipulates its host's DNA, according to a new study published in Nature Communications.

Cytomegalovirus is an ubiquitous herpesvirus that poses a significant threat to solid organ and haematopoietic stem cell transplant recipients. Primary infection, reinfection or reactivation may lead ...

Cytomegalovirus (CMV), a common virus in the Herpesviridae family, infects approximately half of all adults in the United States, most of whom experience mild or no symptoms. While the virus usually ...

Human cytomegalovirus infections are still associated with severe morbidity and mortality in immunocompromised individuals, despite the availability of five drugs that are currently licensed for ...

Bone marrow transplantation is a life-saving therapy for patients with blood cancers like leukemia or lymphoma. However, the depletion of the patient's immune system prior to transplantation can put ...

Federal data indicate that over half the US population aged 6-46 years is infected with cytomegalovirus (CMV), typically spread through bodily fluids. Most people have mild or no negative effects from ...

Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.

EVX-V1 is a next-generation, multi-component vaccine program combining novel AI-discovered antigens with AI-optimized versions of established CMV vaccine antigens COPENHAGEN, Denmark, July 12, 2026 - ...

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology ™ platform, presents new data further supporting the multi-component concept of ...